Fearmongering on SSRIs as a PR Tool

  • by: |
  • 09/24/2007
Alison Bass (a former Boston Globe reporter with a long hate the industry bias) is the latest apologist for the increase in suicides as a result of the fearmongering over SSRIs. In an editorial called "Suicide Rates as a PR Tool" she attributes better mental health care and gun control (!) Really? So how are kids killing themselves now in the wake of better mental health care and stricter gun controls if SSRIs have nothing to do with it. The idiocy of zealot courtesy of another anti-medication fanatic, Univ of Maryland researcher Julie Zito.

Oh, Bass is the author of a forthcoming book entitled, "Side Effects: A Best-selling Drug on Trial." How about fearmongering and demeaning those who have struggled to combat suicide as a PR tool. Where does a suicide denier stack up next to a Holocaust denier.

http://www.boston.com/news/globe/editorial_opinion/



Others like Alex (I stole the documents) Berenson dismiss the number of suicides as so small as to really merit concern. Funny, when Steve (I want to cause people's hands to tremble a little bit before they write that prescription," )Nissen and Curt Furberg were foaming at the mouth about 25 'unexplained' heart attacks among kids taking ADHD drugs over a ten year period that was enough to demand a black box an entire class of drugs and for the NY Times to run story after story validating as opposed to questioning the concerns.

http://www.nytimes.com/2006/02/10/health/policy/10drug.html

http://www.nytimes.com/2006/02/21/health/21psyc.html?fta=y

Keep it coming. Every time these whack jobs and their apologists take a run at the work of Robert Gibbons -- which has been verified by Greg Simon at Group of Health Puget Sound and J. John Mann and many others -- the most extreme and dangerous they appear.
CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog